Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Mergers & acquisitions (M&A) stories

Nov 16, 2026

Eli Lilly acquires Calytrix Bio for up to $1.5B in rare blood cancer push

Eli Lilly agreed to acquire Calytrix Bio for up to $1.5 billion to expand development of treatments for rare blood cancers known as myeloproliferative neoplasms, its 14th or 15th acquisition of 2026.

Nov 16, 2026·3 sources
00
Nov 15, 2026

J&J in talks to acquire eye disease biotech for up to $3.4bn

Johnson & Johnson is poised to acquire a privately held eye disease drug developer in a deal valued at up to $3.4 billion, according to the Financial Times.

Nov 15, 2026·2 sources
00
Nov 10, 2026

AstraZeneca acquires vaccine biotech Omniose to bolster pipeline

AstraZeneca acquired early-stage US biotech Omniose, which is developing vaccines against serious bacterial infections, integrating it into its infectious diseases division.

Nov 10, 2026·2 sources
00
Nov 5, 2026

Siemens Healthineers begins carve-out of diagnostics business

Siemens Healthineers started carving out its diagnostics business, which it plans to rebrand as Olyrian Diagnostics ahead of a future divestment, and will rebrand the parent company as Healthineers.

Nov 5, 2026·2 sources
00
Nov 4, 2026

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm Pharmaceuticals

AstraZeneca made a $10 billion takeover offer for Rhythm Pharmaceuticals, which specializes in treatments for metabolic conditions and severe obesity, according to sources familiar with the matter.

Nov 4, 2026·2 sources
00
Nov 3, 2026

Servier's $1.55 billion muscular dystrophy drug fails pivotal trial

Servier's sevasemten, acquired from Edgewise for $1.55 billion upfront in June 2026, failed its pivotal trial for muscular dystrophy just five months after the acquisition.

Nov 3, 2026·2 sources
00

CrowdStrike to acquire two AI security startups for $495 million

CrowdStrike agreed to buy two artificial intelligence security startups for a combined $495 million to expand monitoring and containment of AI agents as enterprises roll out autonomous systems.

Nov 3, 2026·2 sources
00
Oct 29, 2026

DoorDash acquires Instacart for $17 billion

DoorDash agreed to buy rival grocery delivery service Instacart in a deal valuing the company at approximately $17 billion, marking significant consolidation in the delivery sector.

Oct 29, 2026·2 sources
00

Flagship Pioneering merges Etiome, Cellarity and Empress Therapeutics into Etcelera

Biotechnology startup creator Flagship Pioneering is combining three of its portfolio companies—Etiome, Cellarity, and Empress Therapeutics—into a new venture called Etcelera. The merged company will use artificial intelligence and drug discovery tools to predict which experimental medicines might succeed in clinical trials.

Oct 29, 2026·2 sources
00
Oct 27, 2026

Ferring to acquire fertility startup Gameto for up to $1.38B

Ferring Pharmaceuticals has signed an agreement to acquire fertility startup Gameto in a deal worth up to $1.3825 billion, expanding its reproductive health portfolio.

Oct 27, 2026·2 sources
00
Oct 26, 2026

Intel acquires quantum computing startup Classiq Technologies

Intel agreed to acquire Israeli quantum computing startup Classiq Technologies as part of its push to capitalize on quantum computing applications.

Oct 26, 2026·3 sources
00

GSK to nearly double cancer drugs in clinical trials by 2027

GSK expects to nearly double the number of cancer medicines it is testing in clinical trials next year, according to a Wall Street Journal interview with a company scientist. The expansion follows a dealmaking spree as the British drugmaker accelerates its return to oncology.

Oct 26, 2026·5 sources
00
Oct 25, 2026

Bon Secours nears $6 billion takeover of Bain-backed Surgery Partners

Non-profit health system Bon Secours Mercy Health is in late-stage talks to acquire a majority stake in Surgery Partners, valuing the Bain Capital-backed surgical care provider at approximately $6 billion including debt.

Oct 25, 2026·3 sources
00
Oct 23, 2026

Roche licenses Zymeworks' experimental lung cancer drug ZW209 in deal worth up to $813 million

Roche has entered into a global license and collaboration agreement with Zymeworks for ZW209, a trispecific T cell engager targeting DLL3 for lung cancer treatment. The deal includes $55 million upfront, up to $718 million in milestone payments, and tiered royalties on future sales.

Oct 23, 2026·5 sources
00
Oct 22, 2026

Gilead acquires PepStar inflammation drug program for $1.28 billion

Gilead Sciences will acquire PepStar Therapeutics' oral inflammation drug program, including an experimental IL-23 receptor inhibitor for inflammatory bowel disease, for $1.28 billion upfront in a deal that could compete with Johnson & Johnson's new immunology pill.

Oct 22, 2026·3 sources
00
Oct 21, 2026

EQT agrees to acquire Qiagen in major diagnostics takeover

Swedish private equity firm EQT has agreed to acquire Dutch molecular testing company Qiagen for approximately €9.6 billion ($10.8 billion) in an all-cash voluntary public takeover offer at €46.50 per share, representing a 40.3% premium to the unaffected share price. The deal ends years of takeover speculation surrounding the diagnostics firm.

Oct 21, 2026·4 sources
00
Oct 20, 2026

OpenAI acquires Orchestra Bio to expand into pharmaceutical AI

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development. The acquisition signals OpenAI's expansion into the healthcare sector, following rival Anthropic's similar moves.

Oct 20, 2026·3 sources
00
Oct 13, 2026

Galderma agrees to buy ZO Skin Health for around $1.5B

Skin care company Galderma has agreed to acquire ZO Skin Health for approximately $1.5 billion in a private transaction, according to sources.

Oct 13, 2026·4 sources
00
Oct 7, 2026

Weston family to buy Boots pharmacy chain for $8.9 billion

Canada's Weston family, through holding company Wittington Investments, has agreed to acquire Britain's Boots pharmacy and beauty retail chain from Sycamore Partners and the Pessina family for $8.9 billion. The deal includes Boots' retail operations in the U.K. and Ireland, Boots Opticians, and the No7 Beauty Co.

Oct 7, 2026·9 sources
00
Oct 4, 2026

Schneider Electric nears $20 billion deal to acquire PTC

France's Schneider Electric is nearing a deal to buy US software group PTC for approximately $20 billion, according to Financial Times sources.

Oct 4, 2026·6 sources
00
Sep 21, 2026

Paramount settles state lawsuits, clearing path for $110 billion Warner Bros. Discovery acquisition

Paramount Skydance reached settlements with California and 11 other state attorneys general who sued to block its proposed $110 billion acquisition of Warner Bros. Discovery. The settlement includes terms requiring 30 films annually and penalties for non-compliance.

Sep 21, 2026·5 sources
00
Sep 17, 2026

Judge approves CVS unit Omnicare's bankruptcy plan after $250 million sale

A Texas judge approved a wind-down bankruptcy plan for CVS Health subsidiary Omnicare LLC following the sale of its business operations for $250 million and resolution of a nearly $1 billion judgment related to improperly dispensing prescription drugs.

Sep 17, 2026·3 sources
00
Sep 10, 2026

Bending Spoons acquires Miro for $1.36 billion

Italian technology group Bending Spoons agreed to acquire workplace-collaboration platform Miro in an all-cash transaction valuing the business at $1.36 billion, continuing the company's acquisition spree.

Sep 10, 2026·3 sources
00
Sep 9, 2026

Silver Lake merges French software firms Cegid and Silae in €10 billion deal

Private equity firm Silver Lake is merging two of its French portfolio companies, business management software provider Cegid and payroll platform Silae, to create a European technology group valued at more than €10 billion ($11.6 billion). The deal comes as the software sector grapples with AI disruption.

Sep 9, 2026·3 sources
00
Sep 8, 2026

Justice Department widens antitrust probe into Fox's $22 billion Roku acquisition

The U.S. Department of Justice is expanding its antitrust investigation into Fox's $22 billion deal to acquire streaming platform Roku, with DOJ staff planning to seek additional information from the companies involved.

Sep 8, 2026·2 sources
00

Connecting Excellence Group signs first acquisition deal to convert recruitment earnings into Bitcoin

Connecting Excellence Group (XCE) has signed binding Heads of Terms for its first proposed recruitment acquisition, targeting a specialist UK and U.S. recruitment business that generated £1.79 million in earnings, as part of its strategy to use M&A to convert earnings into Bitcoin.

Sep 8, 2026·1 source
00
Aug 31, 2026

GoPro acquired and pivots into defense, government, robotics and aerospace

GoPro has been acquired and is shifting its business focus from consumer action cameras to defense, government, robotics and aerospace applications, with YouTuber Markiplier becoming the company's single largest shareholder.

Aug 31, 2026·3 sources
00
Aug 18, 2026

Metaplanet to acquire 96% of Super League Enterprise for $134.6M in Bitcoin and cash

Japanese Bitcoin treasury company Metaplanet agreed to invest 2,100 BTC (~$132.1M) plus $2.5M cash to acquire a 95.7% stake in Nasdaq-listed Super League Enterprise, establishing a US-based Bitcoin treasury platform.

Aug 18, 2026·6 sources
00

Leo Pharma acquires worldwide rights to dersimelagon for up to $435M

Danish drugmaker Leo Pharma agreed to acquire worldwide rights to dersimelagon, a late-stage drug candidate for two rare genetic skin diseases, from Tanabe Pharma for up to $435 million in upfront and milestone payments.

Aug 18, 2026·2 sources
00
Aug 17, 2026

Alibaba sells gaming arm for $1.5 billion to boost AI pivot

Alibaba Group is selling its gaming division in a deal worth at least $1.5 billion, redirecting resources toward its artificial intelligence initiatives.

Aug 17, 2026·2 sources
00
Aug 13, 2026

HPE wins court approval for DOJ settlement on $14 billion Juniper Networks acquisition

Hewlett Packard Enterprise secured court approval for its settlement with the US Justice Department over its $14 billion takeover of Juniper Networks, defeating a challenge from Democratic state attorneys general who alleged the settlement was inadequate. The approval clears the path for the acquisition to close.

Aug 13, 2026·4 sources
00

PTC Therapeutics acquires Sangamo's Fabry disease gene therapy for $211M in bankruptcy auction

PTC Therapeutics won the bankruptcy auction for Sangamo Therapeutics' gene therapy assets with a $211 million bid. Sangamo filed for Chapter 11 bankruptcy in June after failing to find strategic alternatives.

Aug 13, 2026·2 sources
00
Aug 12, 2026

Josh Kushner and Bob Iger reportedly buying Los Angeles Lakers for $12.5 billion

Investor Josh Kushner and former Disney CEO Bob Iger are purchasing the Los Angeles Lakers in a record-breaking $12.5 billion deal, according to ESPN sources.

Aug 12, 2026·3 sources
00
Aug 11, 2026

eToro acquires TradeZero for up to $231 million as crypto revenue falls 30%

Trading platform eToro agreed to buy US brokerage TradeZero for up to $231 million while reporting Q2 results showing crypto revenue dropped nearly 30% year-over-year despite beating overall profit estimates.

Aug 11, 2026·4 sources
00
Aug 10, 2026

Jazz Pharmaceuticals to Acquire Actio Biosciences for Up to $1.32 Billion in Rare Epilepsy Deal

Jazz Pharmaceuticals announced a definitive agreement to acquire privately-held Actio Biosciences for $820 million upfront plus up to $500 million in milestone payments, gaining access to ABS-1230, an experimental treatment for KCNT1+ epilepsy, a rare inherited form of the disease with no approved therapies.

Aug 10, 2026·6 sources
00
Aug 6, 2026

Tarsus Pharmaceuticals to Acquire Alkeus for Up to $800M, Gaining Late-Stage Stargardt Disease Drug

Tarsus Pharmaceuticals agreed to acquire privately-held Alkeus Pharmaceuticals for $450 million upfront and up to $800 million total, gaining gildeuretinol (ALK-001), a Phase 3 oral therapy for Stargardt disease. The rare genetic eye condition affects over 36,000 people in the U.S. and currently has no FDA-approved treatment, with pivotal trial data expected in late 2029.

Aug 6, 2026·5 sources
00

KKR Acquires Medicover India's 24-Hospital Network for $1.3 Billion

Global investment firm KKR has signed a definitive agreement to acquire Medicover India, the Indian hospital business of Stockholm-based Medicover, in a deal valued at approximately $1.3 billion (₹10,000-14,250 crore). The acquisition marks KKR's largest healthcare deal in India and includes a 24-hospital network, with plans for additional investment of ₹3,000-4,000 crore for expansion.

Aug 6, 2026·7 sources
00
Aug 4, 2026

Digital Currency Group's Fortitude Mining Acquires 12.5 MW Nebraska Facility for Zcash Operations

Fortitude Mining Holdings, the Zcash mining subsidiary of Digital Currency Group, completed the acquisition of a 12.5 megawatt digital infrastructure facility in Prosser, Nebraska for $6.25 million in cash, with a net outlay of approximately $4.7 million after credits.

Aug 4, 2026·6 sources
00
Aug 3, 2026

Curium to take radiopharma company Lantheus private in $8 billion deal

Nuclear medicine company Curium has struck a deal to take Lantheus Holdings Inc. private in a transaction worth approximately $8 billion.

Aug 3, 2026·2 sources
00

Supernus Pharmaceuticals and Indivior Pharmaceuticals Agree to All-Stock Merger Creating $2.2 Billion CNS Drug Company

Supernus Pharmaceuticals and Indivior Pharmaceuticals announced an all-stock merger to create a combined company with approximately $2.2 billion in annual revenue and a portfolio of 11 commercialized medicines focused on neurological, psychiatric, and addiction-related conditions. The deal, described as a merger of equals, is expected to generate $125 million in cost savings.

Aug 3, 2026·9 sources
00
Jul 30, 2026

Digital Currency Group acquires cryptocurrency exchange Luno

Digital Currency Group acquired British multinational cryptocurrency exchange Luno, expanding DCG's portfolio of crypto businesses after previously holding a stake in the company.

Jul 30, 2026·1 source
00
Jul 27, 2026

Fanatics acquires CFTC-regulated exchange in prediction markets expansion

Fanatics purchased BGC's Water Street Labs and CX Clearinghouse, gaining the ability to list and settle its own event contracts on a federally regulated platform. The deal positions Fanatics to compete directly with DraftKings and FanDuel in the rapidly growing prediction markets sector.

Jul 27, 2026·2 sources
00

Kraken parent company Payward acquires Magic Labs' embedded wallet business as firm rebrands to Newton Labs

Payward, the parent company of cryptocurrency exchange Kraken, has acquired the embedded wallet business from Magic Labs, which is simultaneously undergoing a restructuring and rebranding to Newton Labs.

Jul 27, 2026·1 source
00
Jul 23, 2026

Dassault Systèmes to acquire ArisGlobal for up to $2 billion

Dassault Systèmes agreed to buy drug trial software maker ArisGlobal for as much as $2 billion as the French firm expands its push into life sciences and AI-powered precision medicine.

Jul 23, 2026·2 sources
00
Jul 20, 2026

Samsung Biologics to Acquire Swiss Drugmaker PolyPeptide for $1.8 Billion in All-Cash Deal

Samsung Biologics announced an all-cash tender offer to acquire Switzerland's PolyPeptide Group AG for CHF 1.46 billion ($1.8B), at CHF 44.31 per share — a 6.1% premium to last close and ~40% to the April 10, 2026 undisturbed price, marking South Korea's largest biopharma acquisition.

Jul 20, 2026·6 sources
00
Jul 15, 2026

Stripe and Advent International Make $53 Billion Takeover Offer for PayPal

Payment processor Stripe and private equity firm Advent International have jointly offered to acquire PayPal Holdings for $60.50 per share, valuing the deal at approximately $53 billion. PayPal's stock surged 14-15% following the news.

Jul 15, 2026·7 sources
00
May 18, 2026

Publicis Groupe Acquires LiveRamp for $2.2 Billion to Expand AI Capabilities

French advertising giant Publicis Groupe agreed to acquire US data company LiveRamp in a $2.2 billion deal to deepen its investment in AI-driven marketing infrastructure.

May 18, 2026·1 source
00
May 5, 2026

Bullish Acquires Equiniti for $4.2 Billion to Build Tokenized Securities Infrastructure

Crypto exchange Bullish has agreed to acquire global transfer agent Equiniti in a $4.2 billion deal aimed at building tokenized securities infrastructure, marking a significant move toward traditional finance integration.

May 5, 2026·1 source
00

GameStop Makes $55.5 Billion Takeover Offer for eBay

Video game retailer GameStop offered to acquire eBay for $55.5 billion in an unsolicited bid that could turn hostile if rebuffed. The move would give GameStop control of a company four times its size.

May 5, 2026·2 sources
00

GameStop Proposes $55.5 Billion Unsolicited Bid to Acquire eBay

GameStop unveiled a non-binding $55.5 billion proposal to acquire eBay at $125 per share, a 46% premium, combining cash and stock in equal amounts.

May 5, 2026·4 sources
00
May 3, 2026

Palo Alto Networks to Acquire Portkey AI Gateway Platform

Palo Alto Networks announced its intent to acquire Portkey, a pioneer in AI Gateway technology that provides unified policy enforcement and security across AI models and agents.

May 3, 2026·2 sources
00
Apr 30, 2026

Tether Proposes Three-Way Merger of Twenty One Capital, Strike, and Elektron Energy

Tether has proposed merging NYSE-listed bitcoin treasury company Twenty One Capital with Strike and Elektron Energy, with Strike CEO Jack Mallers and Elektron founder Raphael Zagury taking executive roles. Twenty One Capital shares rose on the news.

Apr 30, 2026·3 sources
00

MoonPay Acquires Israeli Crypto Security Firm Sodot for $100 Million, Launches Institutional Division

MoonPay has acquired crypto key management firm Sodot in a $100 million stock deal and launched a new institutional business division led by former CFTC Acting Chair Caroline Pham. The acquisition provides security infrastructure for MoonPay's expansion into serving banks, asset managers, and trading firms.

Apr 30, 2026·4 sources
00

Top claims

  • ▪Eli Lilly agreed to acquire Wellesley, Massachusetts-based biotech startup Calytrix Bio Inc. for up to $1.5 billion
  • ▪Eli Lilly has pursued company acquisitions throughout 2026 to expand into oncology, hematology, and autoimmune diseases beyond its blockbuster diabetes and weight-loss franchise
  • ▪Existing therapies for myeloproliferative neoplasms include blood transfusions and JAK inhibitor drugs such as Incyte's Jakafi, which manage disease symptoms rather than targeting underlying mutations

People involved

Tony Xu

Subtopics

Pharmaceutical Industry15Mergers and acquisitions11Corporate strategy10Pharma10Drug development9Rare diseases7Private equity6Clinical trials5Healthcare industry5Institutional crypto adoption5Biotech innovation4Crypto exchanges4Drug Policy, Pricing & Approval4AI agents3AI in healthcare3Biotech startup3Biotechnology3Bitcoin3Cancer & Oncology3Corporate consolidation3Corporate restructuring3Crypto3Drug Approval and Clinical Trials3Retail industry3

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories